What is the recommended clarithromycin dose for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clarithromycin Dosing for Children

The recommended clarithromycin dose for children is 15 mg/kg/day divided into 2 doses (given every 12 hours) for treatment of atypical pneumonia caused by Mycoplasma pneumoniae or Chlamydophila pneumoniae 1.

Standard Dosing Recommendations

Based on the 2011 Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines for community-acquired pneumonia, clarithromycin dosing is:

  • 15 mg/kg/day divided into 2 doses (every 12 hours)
  • This is the preferred oral alternative for atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae) 1
  • Treatment duration is typically 5-7 days for atypical pneumonia 2

Age Restrictions and Safety

Important limitation: Clarithromycin is not approved for children under 6 months of age 3. The FDA drug label explicitly states that safety and effectiveness have not been established in pediatric patients under 6 months.

For children ≥7 years old, doxycycline (2-4 mg/kg/day in 2 doses) is an alternative option for atypical pneumonia 1.

Higher Dose Safety Data

While the standard recommendation is 15 mg/kg/day, research has shown that clarithromycin maintains a favorable safety profile even at higher doses:

  • A study of 343 children found that doses up to 30 mg/kg/day or higher were well-tolerated, with no statistically significant difference in adverse events compared to standard dosing 4
  • However, stick to the guideline-recommended 15 mg/kg/day unless there is a specific clinical indication for dose escalation, as higher doses have not been proven more efficacious

Common Pitfalls to Avoid

  1. Do not use extended-release formulations in children: The FDA label clearly states that extended-release clarithromycin tablets are not established for pediatric use 3

  2. Avoid in children with known QT prolongation: Clarithromycin can prolong the QT interval and should be avoided in patients with hypokalemia, hypomagnesemia, or those taking Class IA or III antiarrhythmics 3

  3. Watch for drug interactions: Clarithromycin is a strong CYP3A4 inhibitor and can interact with numerous medications 3, 5

  4. Adjust dose in severe renal impairment: If the child has significant renal dysfunction, consider dose reduction or prolonged dosing intervals 3

Practical Administration

  • Clarithromycin suspension is typically used for children who cannot swallow tablets
  • The most common adverse effects are gastrointestinal (abdominal pain, diarrhea, nausea, dysgeusia), occurring in approximately 17-25% of pediatric patients 4, 6
  • These side effects are generally mild to moderate and rarely require discontinuation

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.